Drawing for CAPILANO

USPTO serial 88425712

CAPILANO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
TRUSILO, KELLY JEAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CAPILANO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Courtney Thompson

Courtney Thompson Fredrikson & Byron, P.A.200 South Sixth Street, Suite 4000Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBDACTIVE
029Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely butter; fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBDACTIVE
031Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basisACTIVE
034Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of liquids other than essential oils for use in electronic cigarettes and oral smokeless vaporizers; e-liquids other than essential oils comprised of hemp derivatives for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD or exclusively for use with goods having a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp, lighters for smokersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 17, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 17, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 22, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2022EX3GSOU EXTENSION 3 GRANTED
Nov 18, 2022EXT3SOU EXTENSION 3 FILED
Nov 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 15, 2022EX2GSOU EXTENSION 2 GRANTED
Jun 15, 2022EXT2SOU EXTENSION 2 FILED
Jun 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2021EX1GSOU EXTENSION 1 GRANTED
Dec 14, 2021EXT1SOU EXTENSION 1 FILED
Dec 14, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 2, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 18, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 30, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 15, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 31, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2021XAECEXAMINER'S AMENDMENT ENTERED
Mar 15, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 15, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Mar 15, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 25, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 8, 2020PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 23, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019DOCKASSIGNED TO EXAMINER
May 30, 2019DOCKASSIGNED TO EXAMINER
May 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance